Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein

Fig. 5

Evaluation the neutralizing abilities of the potent neutralizing nanobodies. a Neutralization potency was measured by using a pseudotyped virus luciferase neutralization assay. b A table summary of pseudotyped neutralization potency for seven nanobodies. IC50 were calculated by fitting a four-parameter logistic curve using Graphpad 5.0. c Neutralization potency of different multivalent nanobodies was performed using fluorescent microscopy and flow cytometry assays

Back to article page